Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-gamma for Pulmonary Tuberculosis
NCT00201123Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Apr 2005
- Primary completion
- Jan 2007
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
Phase 2, randomised trial of interferon gamma-1b in pulmonary tuberculosis (TB) (3 arms), sponsored by NYU Langone Health. Primary endpoint: Sputum Conversion at 8 weeks. Started Apr 2005; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00201123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201123.